Kilari, D., Szabó, A., Bylow, K., Nelson, A. A., Langenstroer, P., Johnson, S., Sivaraman, A., Jacobsohn, K., Fung, C., Kadambi, S. G., Rini, B. I., Reimers, M. A., Alter, R. S., Paul, A. K., Guercio, B. J., Milowsky, M. I. (2025). A phase 2 study of cabozantinib in combination with atezolizumab as neoadjuvant treatment for muscle-invasive bladder cancer, (HCRN GU18-343) ABATE study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.800